Three-year grant includes 2:1 matching program that could yield $1.25 million in new donations
The Leona M. and Harry B. Helmsley Charitable Trusthas awardedUnitio$8.7 million to extend the reach and impact ofT1D Exchange, a nonprofit dedicated to mitigating barriers to research and improving outcomes for people living with type 1 diabetes (T1D).
The three-year grant fromThe Helmsley Charitable Trust, the largest private foundation funder of T1D-related research and programs, includes a 2:1 matching program.
Unitio will use the Helmsley grant to build capacity in key areas that will:
- increase awareness of the T1D Exchange program, particularly within the scientific community;
- develop novel programs to improve clinical care and translate new therapeutics; and
- cultivate new funding sources to ensure long-term stability.
Over 30,000 children and adults in the U.S. are diagnosed annually with type 1 diabetes, and as many as three million are living with the illness, which remains unpreventable and incurable.[1]T1D Exchange is an integrated, patient-centric research model, an ecosystem that is the first to connect all parties in the development process patients, researchers, clinicians and industry and maintain a laser focus on advancing clinical and translational research. Its approach is reflected in the mission of its parent organization, Unitio, which aims to extend the model to other diseases.
Our model is driving faster, more-informed research that will reduce the physical, financial and psychological burden of living with T1D, saidDana Ball, executive director and co-founder of T1D Exchange. Success in the next stage of growth will require adding to our already strong organizational expertise and experience, which this support from the Helmsley Charitable Trust will make possible.